Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023
Lloyd Price
NOVEMBER 25, 2023
This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.
70 
Let's personalize your content